We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




UK Hospital to Perform First Focused Ultrasound Treatment for Essential Tremor

By HospiMedica International staff writers
Posted on 20 Dec 2016
A hospital in London, UK, will become the first institution in the UK to perform a new non-invasive treatment for essential tremor called MR-guided Focused Ultrasound (MRgFUS) thalamic lesioning.

Essential tremor is the most common movement disorder in the UK, and mostly causes hand tremors that make simple tasks such as dressing, eating, holding objects, writing, and even speaking, difficult. More...
Current treatments include medication, and invasive surgery such as thalamotomy, or Deep Brain Stimulation (DBS).

The MRgFUS procedure was pioneered by INSIGHTEC (Tirat HaCarmel, Israel) and is being performed at the Imperial College Healthcare NHS Trust (London, UK). The medical team performing the procedure is using the US FDA-approved INSIGHTEC Exablate Neuro focused ultrasound device for the trial.

The treatment includes applying low energy ultrasound together with Magnetic Resonance Imaging (MRI) scans to identify the thalamus and sub-thalamic areas thought to be responsible for the tremors. When the system locates the target area, a high-intensity ultrasound beam heats and destroys only the target tissue. During the procedure the patient remains fully conscious, lying in an MRI scanner. The effect of the treatment is immediate, and results in a significant reduction of the tremors.

Consultant Neurosurgeon, Mr Dipankar Nandi, said, “I have been performing DBS operations for over 15 years. This breakthrough allows us now to operate on these patients without the significant risks that inserting an electrode 15 cms deep into the brain entails. We are at the cusp of widening the applications of this innovative technology to help a wide variety of patients, some of whom had no therapeutic option before.”

Related Links:
INSIGHTEC
Imperial College Healthcare NHS Trust

Gold Member
12-Channel ECG
CM1200B
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Blood Gas Analyzer
i-Check200
Fetal Monitor
BT-380
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.